Scarica l'app Stockscreener
66.96
6.03%
3.81
Dopo l'orario di chiusura:
66.96
Tarsus Pharmaceuticals Inc Borsa (TARS) Ultime notizie
Tarsus Pharmaceuticals, Inc. $TARS Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Can Tarsus Pharmaceuticals Inc maintain sales growth2026 Setups & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Tarsus Pharmaceuticals (TARS) COO sells 2,989 shares in planned trade - Stock Titan
Tarsus Pharma Stock Up 20% as Insider Sells $839K in RSU-Linked Trade - Yahoo Finance
Tarsus Pharma Stock Up 20% as Insider Sells $839K in RSU-Linked Trade - The Motley Fool
Tarsus to receive $15M milestone after China approves TP-03 eye therapy - MSN
Tarsus earns $15M milestone on China approval of eye drug - Investing.com India
William Blair reiterates Outperform on Tarsus Pharmaceuticals stock By Investing.com - Investing.com Canada
Tarsus Pharmaceuticals shares rise on China drug approval milestone By Investing.com - Investing.com Canada
Tarsus Pharmaceuticals (TARS) Reaches $15M Milestone After TP-03 Approval in China - GuruFocus
Tarsus Pharmaceuticals Achieves $15 Million Milestone Payment Following Regulatory Approval of TP-03 in China - Quiver Quantitative
China clears first Demodex blepharitis treatment for 40 million people - Stock Titan
TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus - Bitget
LifeSci Capital Remains a Buy on Tarsus Pharmaceuticals (TARS) - The Globe and Mail
TARS SEC FilingsTarsus Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
(TARS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Down 16.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Tarsus Pharmaceuticals (TARS) - MSN
Seshadri Neervannan to sell TARS shares (NASDAQ: TARS) — March dispositions listed - Stock Titan
Tarsus Pharmaceuticals Insider Sold Shares Worth $2,364,904, According to a Recent SEC Filing - marketscreener.com
Tarsus Pharmaceuticals Insider Sold Shares Worth $892,528, According to a Recent SEC Filing - marketscreener.com
Tarsus Pharmaceuticals Insider Sold Shares Worth $772,444, According to a Recent SEC Filing - marketscreener.com
Tarsus Pharma Executives Quietly Unload a Wave of Shares in Coordinated Sell-Off - TipRanks
Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Elizabeth Yeu Lin Sells 390 Shares - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Elizabeth Yeu Lin Sells 375 Shares - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Jeffrey Farrow Sells 2,111 Shares - MarketBeat
Insider Selling: Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Sells 2,186 Shares of Stock - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) CEO Bobak Azamian Sells 11,667 Shares - MarketBeat
Bobak Azamian Sells 10,972 Shares of Tarsus Pharmaceuticals (NASDAQ:TARS) Stock - MarketBeat
Dianne Whitfield Sells 4,071 Shares of Tarsus Pharmaceuticals (NASDAQ:TARS) Stock - MarketBeat
Bryan Wahl Sells 4,084 Shares of Tarsus Pharmaceuticals (NASDAQ:TARS) Stock - MarketBeat
Tarsus Pharma CHRO Whitfield sells $839k in shares By Investing.com - Investing.com South Africa
Azamian, Tarsus Pharmaceuticals CEO, sells $2.36m in stock - Investing.com
Tarsus Pharma CMO Lin sells $78k in shares - Investing.com
Tarsus Pharma CMO Lin sells $78k in shares By Investing.com - Investing.com Australia
Azamian, Tarsus Pharmaceuticals CEO, sells $2.36m in stock By Investing.com - Investing.com Australia
Farrow Jeffrey S of Tarsus Pharma sells $439k in shares - Investing.com Australia
Tarsus Pharma COO Neervannan Seshadri sells $772k in shares - Investing.com
Tarsus Pharma general counsel Wahl sells $850k in stock - Investing.com
Tarsus Pharmaceuticals Insiders Sold Shares Worth Over $5.1M - TradingView
Tarsus (NASDAQ: TARS) HR chief sells 12,274 shares in tax-related trades - Stock Titan
Tarsus (NASDAQ: TARS) counsel sells shares to cover RSU tax - Stock Titan
Tarsus Pharmaceuticals (TARS) COO mandated sell-to-cover totals 11,324 shares - Stock Titan
Tax-driven stock sale by Tarsus (TARS) chief commercial officer - Stock Titan
Tarsus (NASDAQ: TARS) CMO sells shares to cover RSU tax withholding - Stock Titan
Tarsus (TARS) officer sells 6,430 shares in mandated tax sell-to-cover - Stock Titan
Tarsus Pharmaceuticals (TARS) CEO sells 34,603 shares to cover taxes - Stock Titan
TARS (NASDAQ: TARS) files notice to sell 2,186 shares via Fidelity - Stock Titan
TARS (NASDAQ: TARS) insider notifies sale of 4,440 shares via Fidelity - Stock Titan
TARS (NASDAQ: TARS) insider filings show proposed sale and recent dispositions - Stock Titan
Dianne Whitfield reports planned stock sales — TARS (NASDAQ: TARS) - Stock Titan
TARS (NASDAQ: TARS) insider sale notice; Bryan Wahl disposed of 8,209 shares - Stock Titan
TARS (NASDAQ: TARS) insider files Form 144 to resell 4,589 shares after vesting - Stock Titan
TARS (NASDAQ: TARS) insider files Rule 144 to offer 390 shares after vesting - Stock Titan
Q1 Earnings Estimate for TARS Issued By Lifesci Capital - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Insider Sell Alert: LINK WILLIAM J PHD Sells 12,500 Shares of Ta - GuruFocus
Tarsus Pharmaceuticals director Link sells $859k in stock By Investing.com - Investing.com Australia
Tarsus Pharmaceuticals director Link sells $859k in stock - Investing.com
William Phd Link Sells 12,500 Shares of Tarsus Pharmaceuticals (NASDAQ:TARS) Stock - MarketBeat
Dianne Whitfield notifies sale of 4,071 TARS shares (NASDAQ: TARS) - Stock Titan
Tarsus Pharmaceuticals Insider Sold Shares Worth $859,819, According to a Recent SEC Filing - marketscreener.com
Insider sale notice: Bryan Wahl to sell 4,125 shares (TARS) - Stock Titan
Bobak Azamian (TARS) files Rule 144 to sell 11,667 vested shares - Stock Titan
TARS (NASDAQ: TARS) reports insider sales and a 3,610-share vesting on Form 144 - Stock Titan
TARS (NASDAQ: TARS) affiliate notifies sale of 2,133 vested shares - Stock Titan
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):